Safety of Estetrol Birth Control Pill Study
Part of Women’s health & pregnancy clinical trials.
This study checks the safety of a newer birth control pill (E4/DRSP) compared to other common pills. It is for women who are just starting one of these pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting one of these birth control pills for the first time: E4/DRSP, EE/DRSP, EE/LNG, EE/NGM, or EE/NETA.
- It has been more than 6 weeks since you gave birth (if you recently had a baby).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking the safety of a new type of birth control pill containing estetrol (E4) and drospirenone (DRSP) compared to a standard pill. It will help doctors understand if this new option is safe for women who start using it.
This study tests a new combination birth control pill to see how it affects blood vessel and heart health in women aged 18–49. Researchers want to understand if this pill is safe and effective compared to standard options.
This study looks at how genes affect the way the body processes birth control pills. You take a low-dose pill for one cycle and have blood draws to measure hormone levels.
This study tests a new birth control pill to see how well it prevents pregnancy and if it's safe. It combines a lower dose of estrogen with a different type of progestogen that blocks male hormones.
This study tests how a birth control pill with only drospirenone (a type of progestin) affects cervical mucus in women who are about to have weight-loss surgery. It will help understand if this pill is a good option for preventing pregnancy after surgery.
This study looks at how a progestin-only birth control pill works in obese women before and after bariatric surgery. It may help find the best way to prevent pregnancy during this time.
Hear when a new Contraception trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.